Vaccines | Tenderlake

Vaccines

Contract Value:
EUR 9M - 9M
Notice Type:
Contract award notice
Published Date:
02 December 2022
Closing Date:
Location(s):
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
Description:
Human Papillomavirus Vaccine (HPV) 2020-2021 (2022-2023)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland.

The contract period is about two years 2020-2021. The procurement contains two options to extend the contract for the periods 2022 and 2023.

The purpose of STM and the Customer is to procure Human Papillomavirus Vaccine required for the National Vaccination Programme in Finland. The tendered Vaccine must be suitable for children aged 10-15 years.

The contract period is about two years 2020-2021. The procurement contains two options to extend the contract for the periods 2022 and 2023.

Awarded to:
Human Papillomavirus Vaccine (HPV) 2020-2021 (2022-2023)
GlaxoSmithKline Oy, Espoo (FI)
Download full details as .pdf
The Buyer:
Ministry of Social Affairs and Health
CPV Code(s):
33651600 - Vaccines